abbisko website screenshot

abbisko

Abbisko Therapeutics (上海和誉生物医药科技有限公司) is a Shanghai-based clinical-stage biopharmaceutical company focused on the discovery and development of innovative small-molecule therapeutics, primarily in oncology. It was surfaced as a portfolio company of Qiming Venture Partners and added to the API Evangelist network as a stub. Enrichment found no public developer API, SDK, documentation, or agent surface — this is a biopharmaceutical R&D company, not an API provider — so no API artifacts apply; only a live domain-security probe was captured.

abbisko is profiled on the APIs.io network. Tagged areas include Company, Biopharmaceutical, Oncology, Drug Discovery, and Small Molecule.

🌐 Visit website 📡 Source on GitHub
3.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0
0 APIs
CompanyBiopharmaceuticalOncologyDrug DiscoverySmall MoleculeHealthcareLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0
Composite quality — 3.3/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Access Clarity 0.0 / 17
Operational Transparency 0.0 / 11
Contract Governance 0.0 / 10
Discoverability 4.3 / 9
Regulatory Posture 1.1 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
Documented Reversibility 0 / 6
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/abbisko: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Abbisko Domain Security

no transport/DNS hardening detected

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Company 1

The organization behind the API

Website
Website

Source (apis.yml)

apis.yml Raw ↑ 
aid: abbisko
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/abbisko.png
name: abbisko
description: Abbisko Therapeutics (上海和誉生物医药科技有限公司) is a Shanghai-based clinical-stage biopharmaceutical company focused on
  the discovery and development of innovative small-molecule therapeutics, primarily in oncology. It was surfaced as a portfolio
  company of Qiming Venture Partners and added to the API Evangelist network as a stub. Enrichment found no public developer
  API, SDK, documentation, or agent surface — this is a biopharmaceutical R&D company, not an API provider — so no API artifacts
  apply; only a live domain-security probe was captured.
url: https://raw.githubusercontent.com/api-evangelist/abbisko/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- qiming
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-17'
x-no-api-surface: true
tags:
- Company
- Biopharmaceutical
- Oncology
- Drug Discovery
- Small Molecule
- Healthcare
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/abbisko-domain-security.yml
- type: Website
  url: https://abbisko.com
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence